Inactive Instrument
Quotes Soligenix Inc OTC Bulletin Board
Stocks
US8342232084
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 08-07 | Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-08 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
Basic data
Market Cap (USD)
5,596,125
Net sales (USD)
0
Free-Float
95.41 %
Free-Float capitalization (USD)
7,839,198
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 5.6M | |
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | |
| -0.10% | +5.25% | +38.50% | +68.51% | 55.41B | |
| +2.78% | +36.87% | +23.00% | +493.09% | 29.43B | |
| -0.30% | +13.64% | +54.71% | +6.07% | 24.12B | |
| -0.93% | +0.60% | -16.89% | -12.00% | 23.31B | |
| +0.95% | +7.03% | +48.07% | -21.15% | 18.37B | |
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | |
| 0.00% | +9.69% | +31.01% | +584.59% | 16.1B | |
| -2.05% | -3.81% | +40.40% | +150.40% | 13.12B | |
| Average | +1.35% | +391.33% | +57.53% | +196.43% | 26.77B | |
| Weighted average by Cap. | +1.75% | +350.63% | +55.76% | +161.62% |
Historical Quotes: Soligenix Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- SNGX Stock
- Stock
- Quotes Soligenix Inc
Select your edition
All financial news and data tailored to specific country editions
